10109223001
Roche
RNA from yeast
dry powder, pkg of 100 g
Synonym(s):
RNA from yeast, RNA
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
biological source
yeast
Quality Level
form
dry powder
packaging
pkg of 100 g
manufacturer/tradename
Roche
color
yellowish to brown
solubility
water: soluble
storage temp.
room temp
Related Categories
General description
RNA from yeast is the total RNA obtained from Candida utilis.
Application
RNA from yeast has been used:
- as a carrier RNA for in situ hybridization
- for RNA coimmunoprecipitation
RNA from yeast has been used:
- to investigate its effect on the formation of transactivation response element (TAR) DNA-binding protein 43 (TDP-43) low-complexity domain (LCD) droplets in phosphate buffer to determine the possible influence of RNA binding on the liquid–liquid phase separation (LLPS) and/or aggregation of TDP-43 LCD
- for biomass fractionation to help with separations to assess the fate of methylphosphonate (MPn) or bicarbonate radiotracers in cells
- in hybridization solution for in situ hybridization
Preparation Note
Working solution: This mixture of total yeast RNA is resuspended with sterile, DEPC-treated double-distilled water or TE buffer to 10 mg/ml if used as carrier.
Analysis Note
Absorbance: RNA: 95%, Pi (phosphate): 0.3%
Other Notes
For life science research only. Not for use in diagnostic procedures.
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Biomolecules, 11(4) (2021-05-01)
Aggregates of TAR DNA-binding protein (TDP-43) are a hallmark of several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS). Although TDP-43 aggregates are an undisputed pathological species at the end stage of these diseases, the molecular changes underlying the initiation of
Cold Spring Harbor protocols, 2009(10), pdb-pdb (2010-02-12)
RNA coimmunoprecipitation (co-IP) experiments are an extension of protein co-IP experiments in which in vivo RNA-protein complexes are investigated. This protocol describes how to perform RNA co-IPs from C. elegans whole-worm extracts. In principle, a protein-specific antibody is used to
Journal of cell science, 134(22) (2021-10-19)
When exposed to stressful conditions, eukaryotic cells respond by inducing the formation of cytoplasmic ribonucleoprotein complexes called stress granules. Here, we use C. elegans to study two proteins that are important for stress granule assembly in human cells - PQN-59
iScience, 24(9), 103076-103076 (2021-09-30)
Systemic lupus erythematosus (SLE) is characterized by a loss of self-tolerance, systemic inflammation, and multi-organ damage. While a variety of therapeutic interventions are available, it has become clear that an early diagnosis and treatment may be key to achieve long
Methods in molecular biology (Clifton, N.J.), 714, 49-70 (2011-03-25)
In several species, axis formation and tissue differentiation are the result of developmental cascades which begin with the localization and translation of key maternal mRNAs in eggs. Localization and anchoring of mRNAs to cortical structures can be observed with high
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service